Integrating Management of Hepatitis C Infection into Primary Care: the Key to Hepatitis C Elimination Efforts
Authors:
- 28 April 2022
- journal article
- review article
- Published by Springer Nature in Journal of General Internal Medicine
- Vol. 37 (13) , 3435-3443
Abstract
Elimination of hepatitis C virus (HCV), a leading cause of liver disease in the USA and globally, has been made possible with the advent of highly efficacious direct acting antivirals (DAAs). DAA regimens offer cure of HCV with 8–12 weeks of a well-tolerated once daily therapy. With increasingly straightforward diagnostic and treatment algorithms, HCV infection can be managed not only by specialists, but also by primary care providers. Engaging primary care providers greatly increases capacity to diagnose and treat chronic HCV and ultimately make HCV elimination a reality. However, barriers remain at each step in the HCV cascade of care from screening to evaluation and treatment. Since primary care is at the forefront of patient contact, it represents the ideal place to concentrate efforts to identify barriers and implement solutions to achieve universal HCV screening and increase curative treatment.Keywords
This publication has 106 references indexed in Scilit:
- Is genotype 3 of the hepatitis C virus the new villain?Hepatology, 2014
- Hepatitis C virus in the new era: Perspectives in epidemiology, prevention, diagnostics and predictors of response to therapyWorld Journal of Gastroenterology, 2014
- Screening for Hepatitis C Virus Infection in Adults: U.S. Preventive Services Task Force Recommendation StatementAnnals of Internal Medicine, 2013
- Blood Tests to Diagnose Fibrosis or Cirrhosis in Patients With Chronic Hepatitis C Virus InfectionAnnals of Internal Medicine, 2013
- Time to Rethink Antiviral Treatment for Hepatitis C in Patients with Coexisting Mental Health/Substance Abuse IssuesDigestive Diseases and Sciences, 2012
- Barriers to hepatitis C treatmentLiver International, 2011
- Outcomes of Treatment for Hepatitis C Virus Infection by Primary Care ProvidersNew England Journal of Medicine, 2011
- Performance of the Aspartate Aminotransferase-to-Platelet Ratio Index for the Staging of Hepatitis C-Related Fibrosis: An Updated Meta-Analysis §ΔHepatology, 2010
- Hepatitis C Treatment for Injection Drug Users: A Review of the Available EvidenceClinical Infectious Diseases, 2009
- Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfectionHepatology, 2006